抑制斯芬戈-1-酸酶:从疗效到机制
1Department of Health Sciences and Biostatistics, School of Health Sciences, Swinburne University of Technology, Hawthorn, Victoria, Australia.
Neurobiology of disease
|July 2, 2024
概括
斯芬戈辛-1酸盐 (S1P) 对许多过程至关重要. 抑制松素-1-酸酶 (SPL) 提供了一种新的治疗策略,但开发用于中枢神经系统的特定SPL抑制剂仍然具有挑战性.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 脂质代谢 脂质代谢是什么
背景情况:
- 氨酸-1酸盐 (S1P) 是一种关键的脂质媒介体,参与细胞增殖,分化,迁移和细胞亡.
- 目前基于S1P的疗法准S1P受体,但由于受体内部化不完全而面临局限性.
- 斯芬哥辛-1-酸盐酶 (SPL) 调节了S1P降解的最后一步,使其成为潜在的治疗点.
研究的目的:
- 通过各种查方法确定报告的SPL抑制剂进行审查和总结.
- 在各种模型系统中讨论这些SPL抑制剂的疗效和作用机制.
- 突出开发选择性SPL抑制剂的挑战和未来方向.
主要方法:
- 对识别和表征SPL抑制剂的研究进行文献综述.
- 对SPL抑制剂疗效的体外和体内数据的分析.
- 讨论用于发现SPL抑制剂的查方法.
主要成果:
- 已经确定了各种SPL抑制剂,证明了调节S1P水平的可行性.
- 目前的SPL抑制剂的特异性是不确定的,这对治疗应用构成了挑战.
- 目前没有SPL抑制剂能够有效地提高中枢神经系统中的S1P水平.
结论:
- 选择性调节SPL活动为调节S1P生物合成提供了一个有希望的途径.
- 需要进一步的研究来开发具有血脑屏障透性的强效和选择性的SPL抑制剂.
- 针对SPL可能会导致针对神经系统疾病的基于S1P的新疗法.
相关概念视频
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
IP3/DAG Signaling Pathway
12.0K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.0K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Feedback Inhibition
53.8K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
53.8K


